Heparin in stroke: not for most, but the controversy lingers
Stroke
.
2003 Jan;34(1):232-3.
doi: 10.1161/01.str.0000047038.86782.30.
Authors
Geoffrey A Donnan
1
,
Stephen M Davis
Affiliation
1
National Stroke Research Institute, Austin and Repatriation Medical Center and the University of Melbourne, Australia. donnan@austin.unimelb.edu.au
PMID:
12511781
DOI:
10.1161/01.str.0000047038.86782.30
No abstract available
Publication types
Comment
MeSH terms
Anticoagulants / adverse effects*
Anticoagulants / therapeutic use
Brain Ischemia / drug therapy*
Heparin / adverse effects*
Heparin / therapeutic use
Humans
Stroke / drug therapy*
Substances
Anticoagulants
Heparin